Bio-Techne
The firm's full-year 2024 revenues were up 2 percent year over year and in line with the consensus Wall Street estimate.
The company’s research-use-only AmplideX Nanopore Carrier Plus kit can interrogate 11 genes underpinning nine common carrier screening conditions.
Spear Bio Raises $45M in Series A Round for Protein-Based Diagnostics Using qPCR Instruments
Bio-Techne co-led the round, with proceeds intended to accelerate development and scale up manufacturing.
The company's Diagnostics and Genomics segment saw revenue growth of 16 percent, while the Protein Sciences segment's revenues declined 2 percent.
Thermo Fisher Scientific, Bio-Techne Forge European Distribution Deal
The agreement enables Bio-Techne to distribute its products to clinical and research labs via Thermo's Fisher Scientific channel in Europe.